Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis

Sun Wei; Hu Guangyuan; Long Guoxian; Wang Junfeng; Liu Dongbo; Hu Guoqing

首页> 外文期刊>Current medical research and opinion >Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis

【24h】

Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗的非小细胞肺癌患者血清蛋白质组学测试的预测价值：荟萃分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective:

机译：目的：

著录项

来源
《Current medical research and opinion》 |2014年第10期|共7页
作者
Sun Wei; Hu Guangyuan; Long Guoxian; Wang Junfeng; Liu Dongbo; Hu Guoqing;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
EGFR inhibitor; Meta-analysis; NSCLC; Prediction; Proteomic test;

机译：EGFR抑制剂;Meta分析;NSCLC;预测;蛋白质组学;

相似文献

外文文献
中文文献
专利

1. Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis [J] . Sun Wei, Hu Guangyuan, Long Guoxian, Current medical research and opinion . 2014,第10期

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗的非小细胞肺癌患者血清蛋白质组学测试的预测价值：荟萃分析
2. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors [J] . Zhang Xiaoqing, Fan Junwei, Li Yuping, Tumour biology : . 2016,第1期

机译：表皮生长因子受体（EGFR）和AKT1的多态性可作为EGFR酪氨酸激酶抑制剂治疗的晚期非小细胞肺癌患者临床结局的可能预测指标
3. The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis [J] . Ding Ding, Yongfeng Yu, Ziming Li, OncoTargets and therapy . 2014,第4期

机译：预处理表皮生长因子受体T790M突变对酪氨酸激酶抑制剂治疗的非小细胞肺癌患者无进展生存的预测作用：荟萃分析
4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors [O] . Si Sun, Hui Yu, Huijie Wang, 2017

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗表皮生长因子受体突变型非小细胞肺癌患者BIM缺失多态性的探索性队列研究和荟萃分析
7. Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations [O] . Paolo Bironzo, Maria Lucia Reale, Tessa Sperone, 2021

机译：表皮生长因子受体（EGFR）突变阳性非小细胞肺癌（NSCLC）患者对酪氨酸激酶抑制剂（TKIS）的临床特征：共突变的预测和预测作用

Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅